Corix Bioscience ROA 2024

Corix Bioscience Aktienanalyse

What does Corix Bioscience do?

Corix Bioscience is a company specialized in the production of cannabinoid-based products. It was founded in 2014 under the name American Housing Income Trust, a holding company focused on the American real estate market. In 2017, the company decided to restructure and change its name to Corix Bioscience. Since then, the company has become one of the leading manufacturers of CBD oils and other cannabinoid-based products. Corix Bioscience's business model is based on state-of-the-art technologies and innovation in the cannabinoid industry. The company collaborates with other firms to develop new products tailored to patient needs. The company aims to provide patients with a natural and safe alternative to conventional medical therapy. Corix Bioscience has five divisions. These include "Corix Bioscience," which focuses on the development of CBD-based products for the European market. "Corix Health" develops cannabinoid-based products specifically tailored to patient needs. "Subsidiaries" is responsible for collaborating with other companies to expand the product offering. "Licensing" offers licenses for technologies and rights to use innovative products. "Research and Development" focuses on advancing research and technologies in the cannabinoid industry. One of Corix Bioscience's most well-known products is CBD oil. It is extracted from specially bred hemp plants and is used for pain relief, anxiety, and other ailments. The company also offers CBD-based cosmetic products and food. Corix Bioscience is headquartered in Fresno, California, and is now internationally active. The company places special emphasis on the quality of its products and uses only natural and certified ingredients. Corix Bioscience advocates for fair and sustainable production and focuses on environmental protection and sustainability. The future prospects for Corix Bioscience are promising. The company operates in a forward-thinking market, focusing on innovation and sustainability. The developments in the market for cannabinoid-based products allow Corix Bioscience to expand its portfolio and offer more patients a natural alternative to conventional medical therapy. Corix Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Corix Bioscience's Return on Assets (ROA)

Corix Bioscience's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Corix Bioscience's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Corix Bioscience's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Corix Bioscience’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Corix Bioscience Stock

What is the Return on Assets (ROA) of Corix Bioscience this year?

The Return on Assets (ROA) of Corix Bioscience is 0 undefined this year.

What was the ROA of Corix Bioscience compared to the previous year?

The ROA of Corix Bioscience has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Corix Bioscience?

A high ROA is advantageous for investors of Corix Bioscience, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Corix Bioscience?

A low ROA can be unfavorable for investors of Corix Bioscience as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Corix Bioscience affect the company?

An increase in ROA of Corix Bioscience can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Corix Bioscience impact the company?

A reduction in the ROA of Corix Bioscience can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Corix Bioscience?

Some factors that can influence the ROA of Corix Bioscience include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Corix Bioscience important for investors?

The ROA of Corix Bioscience is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Corix Bioscience take to improve ROA?

To improve ROA, Corix Bioscience can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Corix Bioscience pay?

Over the past 12 months, Corix Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Corix Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Corix Bioscience?

The current dividend yield of Corix Bioscience is .

When does Corix Bioscience pay dividends?

Corix Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Corix Bioscience?

Corix Bioscience paid dividends every year for the past 0 years.

What is the dividend of Corix Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Corix Bioscience located?

Corix Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Corix Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Corix Bioscience from 6/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/24/2024.

When did Corix Bioscience pay the last dividend?

The last dividend was paid out on 6/24/2024.

What was the dividend of Corix Bioscience in the year 2023?

In the year 2023, Corix Bioscience distributed 0 USD as dividends.

In which currency does Corix Bioscience pay out the dividend?

The dividends of Corix Bioscience are distributed in USD.